Business Information
The group's principal activity is to design, manufacture and market single-patient use products for the anesthesia, respiratory, critical care, sleep therapy and emergency markets. The anesthetic products include face masks, breathing circuits, infusable (disposable pressure infusor), paxpress, general anesthesia systems, temperature probes, vital view and many other products. The respiratory and critical care products include manual resuscitator, blood pressure cuffs, heated humidification systems, heat and moisture exchangers and other related products. On Oct 30, 2003, the group sold its vital pharma subsidiary to pro-clinical, inc. The group sells its products in the United States, Europe, Asia and other foreign markets.
|
Name |
Title
|
Email
|
Terence Wall | Chmn., CEO, Pres. | N/A | Alex Chanin | CIO | N/A | Alan Furler | VP - Research & Development | N/A | Anthony Martino | VP - Quality, Regulatory | N/A | Barry Wicker | Dir., Exec. VP, COO | N/A |
|
Year |
Sales |
Net Income |
2006 | 204,058 | 30,117 | 2005 | 194,037 | 26,389 | 2004 | 183,991 | 22,053
| |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
Click for more Executives |
|
|